Asthma Treatment Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2027

Published on : Dec-2019 | List of Tables : 39 | List of Figures : 102 | No. of Pages : 170 | Report Code : FACT4422MR | Format :

Long-term Asthma Control Medications Accounting for Sizeable Share in Asthma Treatment Market

Long-term asthma control medications are projected to witness a sluggish CAGR of around 2.6% during the forecast period (2020-2027). Despite this, sales performance of these medications would remain significantly high as compared to quick-relief medications, as asthma patients are required to follow a strict medication regime. As a result, quick-relief medications would witness limited adoption at an estimated CAGR of around 1.7% during the forecast period.

Demand prospects for asthma therapeutics are likely to gain strength, owing to increasing awareness among patients regarding this condition. This should have led to linear growth of the asthma treatment market; however, a spurt in the sales of generic drugs, thriving on the back of patent expiration of branded drugs, is projected to limit market potential.

A recent study has been recently added to the broad report repository of Fact.MR, which portends that, the asthma treatment market would record a steady CAGR of 2.3% during the forecast period (2020-2027).

assessing lucrativeness of asthma treatment market by treatment type

For detailed insights on market taxonomy, request a sample copy of the report here.

Growing Popularity of Alternative Therapies to Hinder Lucrative Opportunities for Market Players

Use of antibiotics for the treatment of asthma is debatable, as numerous pieces of literature highlight side-effects regarding their long-term consumption, such as dysphonia, sore throat, increased heart rate, and tremors. This is encouraging patients to adopt alternative therapies as additional panacea to treat asthma.

Though alternative therapies lack designation as the mainstream treatment, Yoga, Unani, and similar therapies are witnessing high adoption in developed countries of North America. However, the trend of replying on alternative therapies is more pronounced in China and India, where these therapies received first recognition. As Asia Pacific is a key destination for medical tourism, the influence of alternative therapies from developing countries is projected to fast-penetrate developed regions, thereby inhibiting significant sales opportunities for market players.

key regions in asthma treatment market

For detailed regional analysis, request a sample copy of the report here.

North America to Hold Pole Position in Asthma Treatment Market; Asia Pacific Market to Gain Pace

North America would retain its pole position in the asthma treatment market, while the market in Asia Pacific is projected to witness the fastest growth rate. During the forecast period, North America would lose its market share to Asia Pacific, as leading players are gradually scrambling towards developing countries such as China and India to cash in on relatively cost-effective production opportunities. For instance, F.Hoffmann-La Roche Ltd. announced the inauguration of a new manufacturing facility for its pharmaceutical division in Shanghai, China.

Additionally, North America accounts for a high concentration of leading players; ones that generally develop branded drugs. On the contrary, players in the Asia Pacific asthma treatment market relatively hold a low market position, and are involved in the development of generic drugs. As a result, threat of patent expiration affects the North American market more adversely than Asia Pacific. On the back of shifting market trends towards Asia Pacific, the regional asthma treatment market is projected to gain significant pace during the forecast period.

Asthma Treatment Market – Scope of the Study

The study on the asthma treatment market is an exclusive study, which has been recently added to the broad report repository of Fact.MR. The study brings to light crucial influencers that have been influencing the growth of the asthma treatment market. This comprehensive study offers analytical insights pertaining to the recent developments in the asthma treatment market, through the analysis of historical data for the period of 2017-2019, while the duration 2020-2027 is considered as the forecast period.

Recalibration of revenue of the asthma treatment market has been carried out in terms of value (US$ Mn). This research report offers exclusive insights into the influential trends that hold high potential to shape the asthma treatment market during the forecast period. Besides this, the report also includes numerous macroeconomic and microeconomic growth indicators that support the growth of the asthma treatment market during the forecast period. This detailed guide offers crucial information into the key dynamics, along with their influence on the asthma treatment market during the forecast period.

The detailed report, in turn, brings to the fore, insightful information about key challenges and threats that could limit the growth potential of players in the asthma treatment market. The study unveils profitable opportunities for manufacturers, which they can adopt to strengthen their position in the global asthma treatment market. With a view of aiding stakeholders in the asthma treatment market, the study comprises a detailed section on the competition analysis.

This exclusive study offers a dashboard view of the asthma treatment market, with detailed information about market players, based on overall revenue, key developments, and their market presence. Additionally, key strategies of players in the asthma treatment market have also been included in this comprehensive study.

For more insights, request sample of this report.

Asthma Treatment Market – Assessment of Key Segments

Authors of this comprehensive study have classified the asthma treatment market into key segments for an in-depth study of the market. Categorisation of the asthma treatment market is based on treatment type, route of administration, distribution channel, and region. This detailed study also offers information about the incremental opportunity present in the asthma treatment market during the forecast period. Key segments considered while studying the asthma treatment market include:

Treatment Type

Route of Administration

Distribution Channel

Region

Long-term Asthma Control Medications

  • Combination Inhalers
  • Inhaled Corticosteroids
  • Long-acting Beta Agonists
  • Leukotriene Modifiers
  • Theophylline
  • Others (reslizumab, benralizumab, etc.)

Inhaled

Hospital Pharmacies

North America

Quick-relief (Rescue) Medications

  • Short-acting Beta Agonists
  • Ipratropium (Atrovent)
  • Oral & Intravenous Corticosteroids

Oral

Retail Pharmacies

Europe

 

Intravenous

Online Pharmacies

Asia Pacific

 

Subcutaneous

 

Latin America

 

 

 

Middle East & Africa

 

Revenue of the asthma treatment market has been estimated in terms of US$ Mn for the period of 2020 to 2027. In addition to this, compound annual growth rate (CAGR %) has been estimated for all segments during the forecast period 2020-2027, considering 2019 as the base year, in the asthma treatment market.

Analysts of the research report have studied the profiles of key companies operating in the asthma treatment market to get a thorough idea of the competitive landscape. Leading, prominent, and emerging players profiled in this exclusive study include Mylan N.V., Teva Pharmaceutical Industries, AstraZeneca PLC., Sunovion Pharmaceutical, Inc., Boehringer Ingelheim, Sanofi, F.Hoffmann-La Roche Ltd., Novartis International AG, GlaxoSmithKline PLC, and Merck & Co., Inc.

Asthma Treatment Market – Research Methodology

The primary objective of this exclusive study on the asthma treatment market is to offer precise estimates and forecasts of the market in terms of value (US$ Mn) for the period of 2020-2027. The secondary objective includes analysis of key market segments exhibiting significant growth rates, leading strategies adopted by players in the asthma treatment market, and recalibrate the adoption rate of asthma treatment in key regions across the world. Top-down and bottom-up approaches have also been adopted by research analysts in order to validate data and statistics to offer accurate market information to stakeholders.

 1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Asthma Treatment Market
4. Market Overview
    4.1.  Introduction
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities 
4.4. Global Asthma Treatment Market Analysis and Forecast, 2020–2027
5. Market Outlook
    5.1. Pipeline Analysis
    5.2. Reimbursement Scenario 
    5.3. Disease Prevalence with Key Countries
6. Global Asthma Treatment Market Analysis and Forecasts, by Treatment Type
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Global Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2020–2027
        6.3.1. Long-term Asthma Control Medications
            6.3.1.1. Inhaled Corticosteroids
            6.3.1.2. Leukotriene Modifiers
            6.3.1.3. Long-acting Beta Agonists
            6.3.1.4. Combination Inhalers
            6.3.1.5. Theophylline
            6.3.1.6. Others (reslizumab, benralizumab, etc.) 
        6.3.2. Quick-relief (rescue) Medications
            6.3.2.1. Short-acting Beta Agonists
            6.3.2.2. Ipratropium (Atrovent)
            6.3.2.3. Oral and Intravenous Corticosteroids
    6.4. Global Asthma Treatment Market Attractiveness, by Treatment Type
7. Global Asthma Treatment Market Analysis and Forecasts, by Route of Administration
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Global Asthma Treatment Market Value (US$) Forecast, by Route of Administration, 2020–2027
        7.3.1. Oral
        7.3.2. Inhaled
        7.3.3. Intravenous
        7.3.4. Subcutaneous
    7.4. Global Asthma Treatment Market Attractiveness, by Route of Administration
8. Global Asthma Treatment Market Analysis and Forecasts, by Distribution Channel
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Global Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2020–2027
        8.3.1. Hospital Pharmacies
        8.3.2. Retail Pharmacies
        8.3.3. Online Pharmacies
    8.4. Global Asthma Treatment Market Attractiveness, by Distribution Channel
9. Global Asthma Treatment Market Analysis and Forecasts, by Region
    9.1. Key Findings
    9.2. Global Asthma Treatment Market Value (US$ Mn) Forecast, by Region
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Global Asthma Treatment Market Attractiveness, by Region
10. North America Asthma Treatment Market Analysis and Forecast
    10.1. Introduction
    10.2. North America Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2020–2027
        10.2.1. Long-term Asthma Control Medications
            10.2.1.1. Inhaled Corticosteroids
            10.2.1.2. Leukotriene Modifiers
            10.2.1.3. Long-acting Beta Agonists
            10.2.1.4. Combination Inhalers
            10.2.1.5. Theophylline
            10.2.1.6. Others (reslizumab, benralizumab, etc.)
        10.2.2. Quick-relief (rescue) Medications
            10.2.2.1. Short-acting Beta Agonists
            10.2.2.2. Ipratropium (Atrovent)
            10.2.2.3. Oral and Intravenous Corticosteroids
    10.3. North America Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2020–2027
        10.3.1. Oral
        10.3.2. Inhaled
        10.3.3. Intravenous
        10.3.4. Subcutaneous
    10.4. North America Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2020–2027
        10.4.1. Hospital Pharmacies
        10.4.2. Retail Pharmacies
        10.4.3. Online Pharmacies
    10.5. North America Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020–2027
        10.5.1. U.S.
        10.5.2. Canada
    10.6. North America Asthma Treatment Market Attractiveness Analysis
        10.6.1. By Treatment Type
        10.6.2. By Route of Administration
        10.6.3. By Distribution Channel
        10.6.4. By Country/Sub-region 
11. Europe Asthma Treatment Market Analysis and Forecast
    11.1. Introduction
    11.2. Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2020–2027
        11.2.1. Long-term Asthma Control Medications
            11.2.1.1. Inhaled Corticosteroids
            11.2.1.2. Leukotriene Modifiers
            11.2.1.3. Long-acting Beta Agonists
            11.2.1.4. Combination Inhalers
            11.2.1.5. Theophylline
            11.2.1.6. Others (reslizumab, benralizumab etc.)
        11.2.2. Quick-relief (rescue) Medications
            11.2.2.1. Short-acting Beta Agonists
            11.2.2.2. Ipratropium (Atrovent)
            11.2.2.3. Oral and Intravenous Corticosteroids
    11.3. Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2020–2027
        11.3.1. Oral
        11.3.2. Inhaled
        11.3.3. Intravenous
        11.3.4. Subcutaneous
    11.4. Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2020–2027
        11.4.1. Hospital Pharmacies
        11.4.2. Retail Pharmacies
        11.4.3. Online Pharmacies
    11.5. Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region , 2020–2027
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Spain
        11.5.5. Italy
        11.5.6. Rest of Europe
    11.6. Europe Asthma Treatment Market Attractiveness Analysis
        11.6.1. By Treatment Type
        11.6.2. By Route of Administration
        11.6.3. By Distribution Channel
        11.6.4. By Country/Sub-region 
12. Asia Pacific Asthma Treatment Market Analysis and Forecast
    12.1. Introduction
    12.2. Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2020–2027
        12.2.1. Long-term Asthma Control Medications
            12.2.1.1. Inhaled Corticosteroids
            12.2.1.2. Leukotriene Modifiers
            12.2.1.3. Long-acting Beta Agonists
            12.2.1.4. Combination Inhalers
            12.2.1.5. Theophylline
            12.2.1.6. Others (reslizumab, benralizumab etc.)
        12.2.2. Quick-relief (rescue) Medications
            12.2.2.1. Short-acting Beta Agonists
            12.2.2.2. Ipratropium (Atrovent)
            12.2.2.3. Oral and Intravenous Corticosteroids
    12.3. Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2020–2027
        12.3.1. Oral
        12.3.2. Inhaled
        12.3.3. Intravenous
        12.3.4. Subcutaneous
    12.4. Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2020–2027
        12.4.1. Hospital Pharmacies
        12.4.2. Retail Pharmacies
        12.4.3. Online Pharmacies
    12.5. Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region , 2020–2027
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Asia Pacific Asthma Treatment Market Attractiveness Analysis
        12.6.1. By Treatment Type
        12.6.2. By Route of Administration
        12.6.3. By Distribution Channel
        12.6.4. By Country/Sub-region 
13. Latin America Asthma Treatment Market Analysis and Forecast
    13.1. Introduction
    13.2. Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2020–2027
        13.2.1. Long-term Asthma Control Medications
            13.2.1.1. Inhaled Corticosteroids
            13.2.1.2. Leukotriene Modifiers
            13.2.1.3. Long-acting Beta Agonists
            13.2.1.4. Combination Inhalers
            13.2.1.5. Theophylline
            13.2.1.6. Others (reslizumab, benralizumab etc.)
        13.2.2. Quick-relief (rescue) Medications
            13.2.2.1. Short-acting Beta Agonists
            13.2.2.2. Ipratropium (Atrovent)
            13.2.2.3. Oral and Intravenous Corticosteroids
    13.3. Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2020–2027
        13.3.1. Oral
        13.3.2. Inhaled
        13.3.3. Intravenous
        13.3.4. Subcutaneous
    13.4. Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2020–2027
        13.4.1. Hospital Pharmacies
        13.4.2. Retail Pharmacies
        13.4.3. Online Pharmacies
    13.5. Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region , 2020–2027
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Latin America Asthma Treatment Market Attractiveness Analysis
        13.6.1. By Treatment Type
        13.6.2. By Route of Administration
        13.6.3. By Distribution Channel
        13.6.4. By Country/Sub-region 
14. Middle East & Africa Asthma Treatment Market Analysis and Forecast
    14.1. Introduction
    14.2. Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2020–2027
        14.2.1. Long-term Asthma Control Medications
            14.2.1.1. Inhaled Corticosteroids
            14.2.1.2. Leukotriene Modifiers
            14.2.1.3. Long-acting Beta Agonists
            14.2.1.4. Combination Inhalers
            14.2.1.5. Theophylline
            14.2.1.6. Others (reslizumab, benralizumab etc.)
        14.2.2. Quick-relief (rescue) Medications
            14.2.2.1. Short-acting Beta Agonists
            14.2.2.2. Ipratropium (Atrovent)
            14.2.2.3. Oral and Intravenous Corticosteroids
    14.3. Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2020–2027
        14.3.1. Oral
        14.3.2. Inhaled
        14.3.3. Intravenous
        14.3.4. Subcutaneous
    14.4. Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2020–2027
        14.4.1. Hospital Pharmacies
        14.4.2. Retail Pharmacies
        14.4.3. Online Pharmacies
    14.5. Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region , 2020–2027
        14.5.1. GCC 
        14.5.2. South Africa
        14.5.3. Rest of Middle East & Africa
    14.6. Middle East & Africa Asthma Treatment Market Attractiveness Analysis
        14.6.1. By Treatment Type
        14.6.2. By Route of Administration
        14.6.3. By Distribution Channel
        14.6.4. By Country/Sub-region 
15. Competition Landscape
    15.1. Market Share Analysis, by Company (2019)
    15.2. Company Profiles
        15.2.1. AstraZeneca 
        15.2.2. Boehringer Ingelheim International GmbH 
        15.2.3. GlaxoSmithKline plc 
        15.2.4. Novartis AG 
        15.2.5. Teva Pharmaceutical Industries Ltd 
        15.2.6. Sumitomo Dainippon Pharma Co., Ltd 
        15.2.7. Merck & Co., Inc. 
        15.2.8. F. Hoffmann-La Roche Ltd. 
        15.2.9. Sanofi 
        15.2.10. Mylan N.V.

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Asthma Treatment Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2027